Lipidated imidazoquinoline derivatives

Details for Australian Patent Application No. 2009308278 (hide)

Owner GlaxoSmithKline Biologicals sa

Inventors Johnson, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009308278

PCT Pub. Number WO2010/048520

Priority 61/229,933 30.07.09 US; 61/224,226 09.07.09 US; 61/108,210 24.10.08 US

Filing date 23 October 2009

Wipo publication date 29 April 2010

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048520 Priority application(s): WO2010/048520

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308283-Systems, apparatuses and methods for cultivating microorganisms and mitigation of gases

2009308276-Multi-chamber material dispensing system and method for making same